Assignee
FRESENIUS KABI ONCOLOGY LTD
IN·30 granted patents·5 pending applications·72 citations·filing 2004–2023
Top patents by PatentIndex Score
35 records- 0193US10525059B2Pharmaceutical compositions comprising AfatinibFRESENIUS KABI ONCOLOGY LTD·Filed 2016·Granted Jan 7, 2020·12 cites·20 claims
- 0291US9440979B2Process for the preparation of pralatrexateFRESENIUS KABI ONCOLOGY LTD·Filed 2013·Granted Sep 13, 2016·25 cites·25 claims
- 0385US9968608B2Pharmaceutical compositions comprising pemetrexed and tromethamineFRESENIUS KABI ONCOLOGY LTD·Filed 2016·Granted May 15, 2018·3 cites·23 claims
- 0483US9421207B2Pharmaceutical compositions comprising pemetrexed and tromethamineFRESENIUS KABI ONCOLOGY LTD·Filed 2013·Granted Aug 23, 2016·4 cites·14 claims
- 0583US7750165B2Metaxalone polymorphsFRESENIUS KABI ONCOLOGY LTD·Filed 2006·Granted Jul 6, 2010·11 cites·7 claims
- 0682US10800763B2Polymorphic forms of Afatinib free base and Afatinib dimaleateFRESENIUS KABI ONCOLOGY LTD·Filed 2016·Granted Oct 13, 2020·3 cites·21 claims
- 0779US11098037B2Process for preparing alectinib or a pharmaceutically acceptable salt thereofFRESENIUS KABI ONCOLOGY LTD·Filed 2018·Granted Aug 24, 2021·1 cites·9 claims
- 0877US8901322B2Crystalline forms of cabazitaxel and process for preparation thereofFRESENIUS KABI ONCOLOGY LTD·Filed 2012·Granted Dec 2, 2014·7 cites·30 claims
- 0976US11883403B2Pharmaceutical compositions comprising AfatinibFRESENIUS KABI ONCOLOGY LTD·Filed 2022·Granted Jan 30, 2024·0 cites·20 claims
- 1074US11465999B2Process for preparing Alectinib or a pharmaceutically acceptable salt thereofFRESENIUS KABI ONCOLOGY LTD·Filed 2021·Granted Oct 11, 2022·0 cites·23 claims
- 1172US9199953B2Amorphous form of cabazitaxel and process for its preparationFRESENIUS KABI ONCOLOGY LTD·Filed 2012·Granted Dec 1, 2015·2 cites·7 claims
- 1268US10544109B2Process for the preparation of xylene linked cyclam compoundsFRESENIUS KABI ONCOLOGY LTD·Filed 2016·Granted Jan 28, 2020·1 cites·15 claims
- 1368US7674824B2Stable oxaliplatin formulationFRESENIUS KABI ONCOLOGY LTD·Filed 2006·Granted Mar 9, 2010·1 cites·12 claims
- 1468US2020138817A1Pharmaceutical compositions comprising afatinibFRESENIUS KABI ONCOLOGY LTD·Filed 2019·Application pending·0 cites
- 1567US11739057B2Polymorphic forms of Belinostat and processes for preparation thereofFRESENIUS KABI ONCOLOGY LTD·Filed 2021·Granted Aug 29, 2023·0 cites·20 claims
- 1667US8927023B2Biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositionsFRESENIUS KABI ONCOLOGY LTD·Filed 2012·Granted Jan 6, 2015·1 cites·17 claims
- 1763US9000193B2Process for the preparation of cabazitaxelFRESENIUS KABI ONCOLOGY LTD·Filed 2014·Granted Apr 7, 2015·0 cites·2 claims
- 1862US11390612B2Polymorphic forms of Afatinib free base and Afatinib dimaleateFRESENIUS KABI ONCOLOGY LTD·Filed 2020·Granted Jul 19, 2022·0 cites·17 claims
- 1961US12540140B2Process for the preparation of remimazolamFRESENIUS KABI ONCOLOGY LTD·Filed 2023·Granted Feb 3, 2026·0 cites·11 claims
- 2061US9643932B2Process for the preparation of bendamustine hydrochlorideFRESENIUS KABI ONCOLOGY LTD·Filed 2014·Granted May 9, 2017·0 cites·11 claims
- 2161US7699987B2Stabilized formulationFRESENIUS KABI ONCOLOGY LTD·Filed 2006·Granted Apr 20, 2010·0 cites·18 claims
- 2260US2022151923A1Stable liquid compositions of pemetrexedFRESENIUS KABI ONCOLOGY LTD·Filed 2021·Application pending·0 cites
- 2359US11059777B2Polymorphic forms of belinostat and processes for preparation thereofFRESENIUS KABI ONCOLOGY LTD·Filed 2017·Granted Jul 13, 2021·0 cites·9 claims
- 2455US9669048B2Stable pharmaceutical composition of 5-aza-2′-deoxycitidineFRESENIUS KABI ONCOLOGY LTD·Filed 2013·Granted Jun 6, 2017·0 cites·15 claims
- 2555US8901327B2Process for the preparation cabazitaxelFRESENIUS KABI ONCOLOGY LTD·Filed 2012·Granted Dec 2, 2014·0 cites·30 claims
- 2654US2020246263A1Stable liquid compositions of pemetrexedFRESENIUS KABI ONCOLOGY LTD·Filed 2018·Application pending·0 cites
- 2753US9108924B2Process for the preparation of bendamustine hydrochlorideFRESENIUS KABI ONCOLOGY LTD·Filed 2012·Granted Aug 18, 2015·0 cites·27 claims
- 2851US2023174444A1Process for the preparation of propofolFRESENIUS KABI ONCOLOGY LTD·Filed 2021·Application pending·0 cites
- 2945US2015073000A1Stable ready-to-use pharmaceutical composition of pemetrexedFRESENIUS KABI ONCOLOGY LTD·Filed 2013·Application pending·0 cites
- 3044US12552742B2Process for the preparation of Semaglutide side chainFRESENIUS KABI ONCOLOGY LTD·Filed 2021·Granted Feb 17, 2026·0 cites·14 claims
- 3144US11078231B2Process for purification of carfilzomib intermediateFRESENIUS KABI ONCOLOGY LTD·Filed 2017·Granted Aug 3, 2021·0 cites·13 claims
- 3243US11667654B2Process for the preparation of boronic acid estersFRESENIUS KABI ONCOLOGY LTD·Filed 2018·Granted Jun 6, 2023·0 cites·18 claims
- 3343US10253066B2Process for purification of CarfilzomibFRESENIUS KABI ONCOLOGY LTD·Filed 2015·Granted Apr 9, 2019·0 cites·13 claims
- 3439US11440912B2Process for the preparation of ribociclib and its saltsFRESENIUS KABI ONCOLOGY LTD·Filed 2018·Granted Sep 13, 2022·0 cites·11 claims
- 3536US7608730B2Process for the preparation of an anti-tumor platinum (II)—complexFRESENIUS KABI ONCOLOGY LTD·Filed 2004·Granted Oct 27, 2009·1 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when FRESENIUS KABI ONCOLOGY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →